Amarin Corp plc\uk vs Heron Therapeutics
Amarin Corp plc\uk is the larger business, with $214m of revenue in fiscal 2025 against $155m for Heron Therapeutics (1.4 times as much). Heron Therapeutics grew faster (7.4% against -6.5%). Heron Therapeutics kept more of each dollar of sales as profit: a net margin of -13.0% against -18.2%. Amarin Corp plc\uk carries less debt relative to equity (0.0% against 228.4%).
| Latest fiscal year | Amarin Corp plc\ukAMRN, 2025 | Heron TherapeuticsHRTX, 2025 |
|---|---|---|
| Revenue | $214m | $155m |
| Revenue growth | -6.5% | 7.4% |
| Net income | −$38.8m | −$20.2m |
| Operating margin | -23.5% | -1.6% |
| Net margin | -18.2% | -13.0% |
| Return on equity | -8.2% | — |
| Free cash flow | $6.7m | −$27.9m |
| Cash | $135m | $28.6m |
| Total debt | $0 | $32.7m |
| Debt to equity | 0.0% | 228.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 80 | 128 |
| Market value | $254m | $52.7m |
| Price vs our value range | — | — |
| Moat score | 28 (Weak) | 17 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |